• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad , Dec. 23

THE equity holding of Goldman Sachs Investments (Mauritius) I Ltd in Suven Life Sciences Ltd has crossed the threshold limit of five per cent.

Suven Life has informed the stock exchanges on Thursday that Goldman Sachs has acquired 41,000 equity shares aggregating 0.16 per cent of the total paid-up capital of the company on December 21.

The mode of acquisition was through the open market and the shareholding of Goldman Sachs after the said acquisition stands at 1,271,459 shares aggregating 5.09 per cent of the paid-up capital of the company.

More Stories on : Foreign Institutional Investors | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Catholic Syrian Bank to market SBI MF plans

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line